(Q51666183)

9 April 2018

title

Membrane fatty acid levels as a predictor of treatment response in chronic schizophrenia (English)

1 reference

https://api.crossref.org/works/10.1016/J.PSYCHRES.2010.07.049

3 July 2024

0 references

0 references

Tomiki Sumiyoshi

1

1 reference

9 April 2018

Yuko Higuchi

2

1 reference

9 April 2018

Mie Matsui

3

1 reference

9 April 2018

Hiroko Itoh

4

1 reference

9 April 2018

Takashi Uehara

5

1 reference

9 April 2018

Toru Itoh

6

1 reference

9 April 2018

Hirofumi Arai

7

1 reference

9 April 2018

Chieko Takamiya

8

1 reference

9 April 2018

Michio Suzuki

9

1 reference

9 April 2018

Masayoshi Kurachi

10

1 reference

9 April 2018

language of work or name

English

0 references

publication date

1 March 2011

1 reference

9 April 2018

30 March 2011

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20800904

full work available at URL

3 July 2024

https://api.elsevier.com/content/article/PII:S0165178110004816?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.PSYCHRES.2010.07.049

https://api.elsevier.com/content/article/PII:S0165178110004816?httpAccept=text/plain

3 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.PSYCHRES.2010.07.049

3 July 2024

1 reference

9 April 2018

volume

186

1 reference

9 April 2018

issue

1

1 reference

9 April 2018

page(s)

23-27

1 reference

9 April 2018

Supplementation with a combination of omega-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia

cites work

3

1 reference

https://api.crossref.org/works/10.1016/J.PSYCHRES.2010.07.049

Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients

3 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.PSYCHRES.2010.07.049

Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group

3 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.PSYCHRES.2010.07.049

3 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.PSYCHRES.2010.07.049

A breakdown of event schemas in patients with schizophrenia: an examination of their script for dining at restaurants

3 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.PSYCHRES.2010.07.049

Semantic memory in schizophrenia: association with cell membrane essential fatty acids

3 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.PSYCHRES.2010.07.049

Red cell membrane fatty acids, cytosolic phospholipase-A2 and schizophrenia

3 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.PSYCHRES.2010.07.049

Plasma polyunsaturated fatty acids and regional cerebral glucose metabolism in major depression

3 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.PSYCHRES.2010.07.049

Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment

3 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.PSYCHRES.2010.07.049

Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia

3 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.PSYCHRES.2010.07.049

A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases

3 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.PSYCHRES.2010.07.049

Predicting drug efficacy for cognitive deficits in schizophrenia

3 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.PSYCHRES.2010.07.049

Fish consumption and major depression

3 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.PSYCHRES.2010.07.049

Electrophysiological basis for the ability of olanzapine to improve verbal memory and functional outcome in patients with schizophrenia: a LORETA analysis of P300.

3 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.PSYCHRES.2010.07.049

The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia

3 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.PSYCHRES.2010.07.049

Metabolomic mapping of atypical antipsychotic effects in schizophrenia.

3 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.PSYCHRES.2010.07.049

Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics

3 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.PSYCHRES.2010.07.049

Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients.

3 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.PSYCHRES.2010.07.049

Fatty acid composition in major depression: decreased ω3 fractions in cholesteryl esters and increased C20:4ω6C20:5ω3 ratio in cholesteryl esters and phospholipids

3 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.PSYCHRES.2010.07.049

Impairment of event schema in patients with schizophrenia: examination of script for shopping at supermarket

3 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.PSYCHRES.2010.07.049

Chronic risperidone treatment preferentially increases rat erythrocyte and prefrontal cortex omega-3 fatty acid composition: evidence for augmented biosynthesis

3 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.PSYCHRES.2010.07.049

Abnormalities in the fatty acid composition of the postmortem orbitofrontal cortex of schizophrenic patients: gender differences and partial normalization with antipsychotic medications

3 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.PSYCHRES.2010.07.049

Serotonin receptors: their key role in drugs to treat schizophrenia

3 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.PSYCHRES.2010.07.049

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

3 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.PSYCHRES.2010.07.049

The n-3 polyunsaturated fatty acid/dopamine hypothesis of schizophrenia

3 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.PSYCHRES.2010.07.049

A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms

3 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.PSYCHRES.2010.07.049

Depleted red cell membrane essential fatty acids in drug-treated schizophrenic patients

3 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.PSYCHRES.2010.07.049

Common effect of antipsychotics on the biosynthesis and regulation of fatty acids and cholesterol supports a key role of lipid homeostasis in schizophrenia

3 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.PSYCHRES.2010.07.049

Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients

3 July 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.PSYCHRES.2010.07.049

Reduced red blood cell membrane essential polyunsaturated fatty acids in first episode schizophrenia at neuroleptic-naive baseline

3 July 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.PSYCHRES.2010.07.049

Associations between central and peripheral measures of phospholipid breakdown revealed by cerebral 31-phosphorus magnetic resonance spectroscopy and fatty acid composition of erythrocyte membranes.

3 July 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.PSYCHRES.2010.07.049

Prediction of short-term changes in symptom severity by baseline plasma homovanillic acid levels in schizophrenic patients receiving clozapine

3 July 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.PSYCHRES.2010.07.049

Effect of perospirone on P300 electrophysiological activity and social cognition in schizophrenia: a three-dimensional analysis with sloreta

3 July 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.PSYCHRES.2010.07.049

Essential polyunsaturated fatty acids and social cognition in schizophrenia.

3 July 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.PSYCHRES.2010.07.049

Prediction of changes in memory performance by plasma homovanillic acid levels in clozapine-treated patients with schizophrenia

3 July 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.PSYCHRES.2010.07.049

A double-blind trial of essential fatty acid supplementation in patients with tardive dyskinesia.

3 July 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.PSYCHRES.2010.07.049

Correlations between peripheral polyunsaturated fatty acid content and in vivo membrane phospholipid metabolites

3 July 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.PSYCHRES.2010.07.049

Red blood cell membrane dynamics in schizophrenia. I. Membrane fluidity

3 July 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.PSYCHRES.2010.07.049

Red blood cell membrane dynamics in schizophrenia. III. Correlation of fatty acid abnormalities with clinical measures

3 July 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.PSYCHRES.2010.07.049

Red blood cell membrane dynamics in schizophrenia. II. Fatty acid composition

3 July 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.PSYCHRES.2010.07.049

3 July 2024

Identifiers

1 reference

9 April 2018

1 reference

9 April 2018